These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28100496)

  • 21. Kinetics of the antibody response to seasonal influenza vaccination among the elderly.
    Kositanont U; Assantachai P; Wasi C; Puthavathana P; Praditsuwan R
    Viral Immunol; 2012 Dec; 25(6):471-6. PubMed ID: 23061793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study.
    Sundaram ME; Meydani SN; Vandermause M; Shay DK; Coleman LA
    Nutr Res; 2014 Feb; 34(2):149-54. PubMed ID: 24461316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.
    Zhan Y; Yang Z; Li L; Ye D; Wu H; Fu R; Zhao S; Wang Y; Zhou R; Chen R
    Jpn J Infect Dis; 2011; 64(3):190-4. PubMed ID: 21617301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants.
    Halasa NB; Gerber MA; Chen Q; Wright PF; Edwards KM
    J Infect Dis; 2008 May; 197(10):1448-54. PubMed ID: 18444800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.
    Tsurudome Y; Kimachi K; Okada Y; Matsuura K; Ooyama Y; Ibaragi K; Kino Y; Ueda K
    Microbiol Immunol; 2015 Oct; 59(10):597-604. PubMed ID: 26272602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody responses after inactivated influenza vaccine in young children.
    Wright PF; Sannella E; Shi JR; Zhu Y; Ikizler MR; Edwards KM
    Pediatr Infect Dis J; 2008 Nov; 27(11):1004-8. PubMed ID: 18833023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty.
    DiazGranados CA; Dunning AJ; Robertson CA; Talbot HK; Landolfi V; Greenberg DP
    Vaccine; 2015 Aug; 33(36):4565-71. PubMed ID: 26187260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance.
    Kosikova M; Li L; Radvak P; Ye Z; Wan XF; Xie H
    Clin Infect Dis; 2018 Oct; 67(10):1523-1532. PubMed ID: 29672713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).
    Skowronski DM; Janjua NZ; De Serres G; Purych D; Gilca V; Scheifele DW; Dionne M; Sabaiduc S; Gardy JL; Li G; Bastien N; Petric M; Boivin G; Li Y
    J Infect Dis; 2012 Dec; 206(12):1852-61. PubMed ID: 22872731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials.
    Zhao X; Fang VJ; Ohmit SE; Monto AS; Cook AR; Cowling BJ
    Epidemiology; 2016 Jan; 27(1):143-51. PubMed ID: 26427723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
    J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner.
    Marcelin G; Bland HM; Negovetich NJ; Sandbulte MR; Ellebedy AH; Webb AD; Griffin YS; DeBeauchamp JL; McElhaney JE; Webby RJ
    J Infect Dis; 2010 Dec; 202(11):1634-8. PubMed ID: 20979454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.
    Cate TR; Rayford Y; Niño D; Winokur P; Brady R; Belshe R; Chen W; Atmar RL; Couch RB
    Vaccine; 2010 Feb; 28(9):2076-9. PubMed ID: 20044052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial.
    Dunning AJ; DiazGranados CA; Voloshen T; Hu B; Landolfi VA; Talbot HK
    Clin Vaccine Immunol; 2016 Jan; 23(3):228-35. PubMed ID: 26762363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong.
    Tam YH; Valkenburg SA; Perera RAPM; Wong JHF; Fang VJ; Ng TWY; Kwong ASK; Tsui WWS; Ip DKM; Poon LLM; Chau CKV; Barr IG; Peiris JSM; Cowling BJ
    Clin Infect Dis; 2018 Mar; 66(6):904-912. PubMed ID: 29069368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.
    Brickley EB; Wright PF; Khalenkov A; Neuzil KM; Ortiz JR; Rudenko L; Levine MZ; Katz JM; Brooks WA
    Clin Infect Dis; 2019 Aug; 69(5):786-794. PubMed ID: 30481269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.
    Black S; Nicolay U; Vesikari T; Knuf M; Del Giudice G; Della Cioppa G; Tsai T; Clemens R; Rappuoli R
    Pediatr Infect Dis J; 2011 Dec; 30(12):1081-5. PubMed ID: 21983214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains.
    Reber AJ; Kim JH; Coleman LA; Spencer SM; Chung JR; Chen J; Gargiullo P; Sundaram ME; Belongia EA; Shay DK; Katz JM; Sambhara S
    J Infect Dis; 2016 Nov; 214(10):1477-1486. PubMed ID: 27571905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.